Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells

Sorafenib, a tyrosine kinase inhibitor, has been demonstrated to exert anti-tumor effects. However, the molecular mechanisms underlying its effects on bladder cancer remain unknown. Here, we evaluated the mechanisms responsible for the sorafenib-induced anti-tumor effects on 5637 and T24 bladder can...

Descripción completa

Detalles Bibliográficos
Autores principales: Amantini, Consuelo, Morelli, Maria Beatrice, Santoni, Matteo, Soriani, Alessandra, Cardinali, Claudio, Farfariello, Valerio, Eleuteri, Anna Maria, Bonfili, Laura, Mozzicafreddo, Matteo, Nabissi, Massimo, Cascinu, Stefano, Santoni, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468325/
https://www.ncbi.nlm.nih.gov/pubmed/26097873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468325/
https://www.ncbi.nlm.nih.gov/pubmed/26097873

Ejemplares similares